Revisiting the Hallmarks of Aging to Identify Markers of Biological Age

被引:0
作者
Florent Guerville
P. De Souto Barreto
I. Ader
S. Andrieu
L. Casteilla
C. Dray
N. Fazilleau
S. Guyonnet
D. Langin
R. Liblau
A. Parini
P. Valet
N. Vergnolle
Y. Rolland
B. Vellas
机构
[1] Toulouse University Hospital (CHU Toulouse),Gerontopole of Toulouse, Institute of Ageing
[2] University of Toulouse III,Inserm UMR1027
[3] Université Paul Sabatier,STROMALab, University of Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031
[4] CHU Toulouse,Department of Epidemiology and Public Health
[5] University of Toulouse III,Institut des Maladies Métaboliques et Cardiovasculaires, Inserm UMR1048
[6] University of Toulouse III,Centre de Physiopathologie de Toulouse Purpan, Inserm UMR1043, CNRS UMR5282
[7] Toulouse University Hospital (CHU Toulouse),Department of Medical Biochemistry
[8] University of Toulouse III,Institut de Recherche en Santé Digestive, Inserm UMR1220, INRA UMR1416
[9] Gérontopôle de Toulouse,Institut du Vieillissement
来源
The Journal of Prevention of Alzheimer's Disease | 2020年 / 7卷
关键词
Biomarkers; biological age; healthy aging; frailty; geroscience;
D O I
暂无
中图分类号
学科分类号
摘要
The Geroscience aims at a better understanding of the biological processes of aging, to prevent and/or delay the onset of chronic diseases and disability as well as to reduce the severity of these adverse clinical outcomes. Geroscience thus open up new perspectives of care to live a healthy aging, that is to say without dependency. To date, life expectancy in healthy aging is not increasing as fast as lifespan. The identification of biomarkers of aging is critical to predict adverse outcomes during aging, to implement interventions to reduce them, and to monitor the response to these interventions. In this narrative review, we gathered information about biomarkers of aging under the perspective of Geroscience. Based on the current literature, for each hallmark of biological aging, we proposed a putative biomarker of healthy aging, chosen for their association with mortality, age-related chronic diseases, frailty and/or functional loss. We also discussed how they could be validated as useful predictive biomarkers.
引用
收藏
页码:56 / 64
页数:8
相关论文
共 295 条
  • [71] Horvath S(2019)Circulating osteogenic precursor cells: Building bone from blood EBioMedicine 39 603-95
  • [72] Field AE(2015)Association between circulating osteogenic progenitor cells and disability and frailty in older persons: the Nepean osteoporosis and frailty study J Gerontol Ser Biomed Sci Med Sci 71 1124-10
  • [73] Robertson NA(2003)Centenarians as a model for healthy aging Biochem Soc Trans 31 457-44
  • [74] Wang T(2015)Neuroinflammation in Alzheimer’s Disease Lancet Neurol 14 388-9
  • [75] Marioni RE(2002)The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta Mol Cell 10 417-26
  • [76] Shah S(2013)Canonical Nlrp3 Inflammasome Links Systemic Low-Grade Inflammation to Functional Decline in Aging Cell Metab 18 519-53
  • [77] McRae AF(2017)Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states Nat Med 23 174-93
  • [78] Zhang Y(2010)NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals Nature 464 1357-215
  • [79] Wilson R(2012)NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice Nature 493 674-6
  • [80] Heiss J(2017)Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease Nature 552 355-18